Metabolic engineering of Komagataella phaffii for the efficient utilization of methanol
Microbial Cell Factories · 2024
DOI: 10.1186/s12934-024-02475-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Cell Factories, 2024. Verfasst von Yuanyuan Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Key Laboratory of Fermentation and Enzyme Engineering, School of Biology and Biological Engineering, South China University of Technology, …. Hauptthemen laut MEDLINE: Methanol, Saccharomycetales, Metabolic Engineering. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Background
Komagataella phaffii , a type of methanotrophic yeast, can use methanol, a favorable non-sugar substrate in eco-friendly bio-manufacturing. The dissimilation pathway in K. phaffii leads to the loss of carbon atoms in the form of CO 2 . However, the ΔFLD strain, engineered to lack formaldehyde dehydrogenase—an essential enzyme in the dissimilation pathway—displayed growth defects when exposed to a methanol-containing medium.
Results
Inhibiting the dissimilation pathway triggers an excessive accumulation of formaldehyde and a decline in the intracellular NAD + /NADH ratio. Here, we designed dual-enzyme complex with the alcohol oxidase1/dihydroxyacetone synthase1 (Aox1/Das1), enhancing the regeneration of the formaldehyde receptor xylulose-5-phosphate (Xu5P). This strategy mitigated the harmful effects of formaldehyde accumulation and associated toxicity to cells. Concurrently, we elevated the NAD + /NADH ratio by overexpressing isocitrate dehydrogenase in the TCA cycle, promoting intracellular redox homeostasis. The OD 600 of the optimized combination of the above strategies, strain DF02-1, was 4.28 times higher than that of the control strain DF00 (Δ FLD , HIS4 + ) under 1% methanol. Subsequently, the heterologous expression of methanol oxidase Mox from Hansenula polymorpha in strain DF02-1 resulted in the recombinant strain DF02-4, which displayed a growth at an OD 600 4.08 times higher than that the control strain DF00 in medium containing 3% methanol.
Conclusions
The reduction of formaldehyde accumulation, the increase of NAD + /NADH ratio, and the enhancement of methanol oxidation effectively improved the efficient utilization of a high methanol concentration by strain ΔFLD strain lacking formaldehyde dehydrogenase. The modification strategies implemented in this study collectively serve as a foundational framework for advancing the efficient utilization of methanol in K. phaffii .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Key Laboratory of Fermentation and Enzyme Engineering, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, China.
- School of Light Industry and Engineering, South China University of Technology, Guangzhou, China.
- Guangdong Key Laboratory of Fermentation and Enzyme Engineering, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, China. syhan@scut.edu.cn.
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Wang, Y., Li, R., Zhao, F., Wang, S., Zhang, Y., Fan, D., & Han, S. (2024). Metabolic engineering of Komagataella phaffii for the efficient utilization of methanol. Microbial Cell Factories. https://doi.org/10.1186/s12934-024-02475-1
Vancouver
Wang Y, Li R, Zhao F, Wang S, Zhang Y, Fan D, et al. Metabolic engineering of Komagataella phaffii for the efficient utilization of methanol. Microbial Cell Factories. 2024. doi:10.1186/s12934-024-02475-1
BibTeX
@article{Wang2024,
author = {Wang, Yuanyuan and Li, Ruisi and Zhao, Fengguang and Wang, Shuai and Zhang, Yaping and Fan, Dexun and Han, Shuangyan},
title = {Metabolic engineering of Komagataella phaffii for the efficient utilization of methanol},
journal = {Microbial Cell Factories},
year = {2024},
doi = {10.1186/s12934-024-02475-1}
}
EUVIMED